So, what do you say to a man who has a PhD and a resume that reads like the prefix to a novel? It all depends on if his record of service includes such names as EPIRUS Biopharmaceuticals, Amersham Health, Ilypsa Inc, Cubist Pharmaceuticals Inc, Nycomed Salutar, Catalytica Pharmaceuticals and a cadre of other fine businesses and organizations. In that case, you would start the conversation by saying “hello” to Scott M. Rocklage, PhD.
The conversation might then flow to one of the hundred different projects that he personally has a hand on and the patents under his name as well. Then the back and forth just might continue to naturally sway toward his position as CEO of 5AM Ventures. This is where the real inspiration and driving force behind this businessman can really be appreciated and explained.
The purpose and drive of the services his business provides is to be crucial in the formative stages of any life science business and supportive in the development of that company’s model. To do this, Scott M. Rocklage’s days are anything but typical and he can be seen discovering new breakthroughs in bioscience, or managing his companies portfolios, and even giving a little time to board meetings and other executive duties. But, when he’s not doing those things he’s often working with his clientele to help them realize the full potential of their ideas and execute them in the most efficient and proactive way as possible.
He’s most excited about working with professionals in the genome business who developed Target medicines that work in sales at a near miraculous level. His business is making science big business and helping others along the way. As a entrepreneur, he’s very goal oriented, focused and not afraid to take risks when it comes to seeing innovation in his daily service. For his success strategy, he recommends sticking to the script. However, he’s also not afraid to fix a mistake quickly once it has been made. For Scott, it’s all about having the right team and management for seeing success in his field, which surprisingly enough is not really affected by the tech communication craze.
Connect with Dr. Scott Rocklage on LinkedIn.